MedShape Solutions Announces Clinical Use of ExoShape CL During ACL Reconstruction

MedShape Solutions, an orthopedic device company based in Atlanta, has introduced the first human clinical use of ExoShape CL, a two-part PEEK Altera interference fixation designed to improve soft tissue graft fixation during ACL reconstructive surgery, according to a company news release.

Advertisement

Champ L. Baker, Jr., MD, performed the procedure at Jack Hughston Memorial Hospital in Phoenix City, Ala. The company intends to make a full market release of its FDA 510(k)-approved ExoShape device in June 2011.

The device features a non-rotational deployment technique designed to preserve the soft tissue graft bundle orientation and tension during single-tunnel double-bundle procedures. The use of MedShape’s proprietary PEEK Altera polymer allows the sheath to be pre-compressed for easy insertion and then expand for graft-to-tunnel compression.

Read the MedShape Solutions news release on the ExoShape.

Read other coverage on orthopedic and spine implant news:

– OrthoSensor Receives $21M in Series B Financing

– ConforMIS Receives FDA Approval for iTotal Patient-Specific Total Knee Replacement

– X-Spine Receoves FDA 510(k) Clearance on AXLE Interspinous Fusion System

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.